Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, Par Value $0.001
-
Shares outstanding
-
12,939,536
-
Total 13F shares
-
26,461,278
-
Share change
-
-1,206,200
-
Total reported value
-
$25,140,343
-
Put/Call ratio
-
22%
-
Price per share
-
$0.95
-
Number of holders
-
60
-
Value change
-
-$1,342,196
-
Number of buys
-
17
-
Number of sells
-
34
Institutional Holders of Marker Therapeutics, Inc. - Common Stock, Par Value $0.001 (MRKR) as of Q4 2021
As of 31 Dec 2021,
Marker Therapeutics, Inc. - Common Stock, Par Value $0.001 (MRKR) was held by
60 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
26,461,278 shares.
The largest 10 holders included
NEA Management Company, LLC, Aisling Capital Management LP, VANGUARD GROUP INC, Long Focus Capital Management, LLC, RENAISSANCE TECHNOLOGIES LLC, MILLENNIUM MANAGEMENT LLC, VICTORY CAPITAL MANAGEMENT INC, TWO SIGMA ADVISERS, LP, KENNEDY CAPITAL MANAGEMENT, INC., and TWO SIGMA INVESTMENTS, LP.
This page lists
60
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.